Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02601027 · ClinicalTrials.gov registry record · Phase 3
Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA
A Phase 3 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT02601027: Completed Phase 3 study, sponsored by Stanford University.
NCT02601027 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02601027, a Phase 3 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
The primary objective is to determine if pre-operative transversus abdominis plane (TAP) nerve blocks by continued infusion of local anesthetic post-operatively affects post-operative narcotic usage, as compared to a placebo TAP block, after breast reconstruction surgery.
Interventions
- DRUG Acetominophen
- DRUG Hydromorphone
- PROCEDURE Transversus Abdominis Plane (TAP) block
- DEVICE Nimbus Infusion Pump IV Administration
- DRUG Bupivacaine infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-11 |
| Est. Completion | 2021-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02601027
The ClinicalTrials.gov registry entry for NCT02601027 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acetominophen is the first listed.
NCT02601027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02601027 about?
NCT02601027 is a clinical study titled "Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA". The primary objective is to determine if pre-operative transversus abdominis plane (TAP) nerve blocks by continued infusion of local anesthetic post-operatively affects post-operative narcotic usage, as compared to a placebo TAP block, after breast reconstruction surgery.
What is the current status of trial NCT02601027?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2015-11. Estimated completion is 2021-06.
What interventions are being tested in trial NCT02601027?
The interventions under investigation include: Acetominophen (DRUG), Hydromorphone (DRUG), Transversus Abdominis Plane (TAP) block (PROCEDURE), Nimbus Infusion Pump IV Administration (DEVICE), Bupivacaine infusion (DRUG).
Who is sponsoring clinical trial NCT02601027?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.